Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (231-240 of 288) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
Clinical Rheumatology|September 16, 2019
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitisKatalin Gulyás, Ágnes Horváth, Edit Végh, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network MeetingRobin Waxman, Carmel Stober, Deepak R Jadon, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
The Journal of Rheumatology|June 3, 2015
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation RequirementsFrances Humby, Stephen Kelly, Serena Bugatti, et al.
Annals of the Rheumatic Diseases|June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysisTommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
Annals of the Rheumatic Diseases|February 26, 2011
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgarisJohn Bowes, Steve Eyre, Edward Flynn, et al.
Seminars in Arthritis and Rheumatism|October 18, 2017
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiativePil Højgaard, Louise Klokker, Ana-Maria Orbai, et al.
BMC Musculoskeletal Disorders|September 24, 2021
Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patientsBalázs Juhász, Katalin Gulyás, Ágnes Horváth, et al.
Pageof 29

Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
Clinical Rheumatology|September 16, 2019
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitisKatalin Gulyás, Ágnes Horváth, Edit Végh, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network MeetingRobin Waxman, Carmel Stober, Deepak R Jadon, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
The Journal of Rheumatology|June 3, 2015
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation RequirementsFrances Humby, Stephen Kelly, Serena Bugatti, et al.
Annals of the Rheumatic Diseases|June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysisTommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
Annals of the Rheumatic Diseases|February 26, 2011
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgarisJohn Bowes, Steve Eyre, Edward Flynn, et al.
Seminars in Arthritis and Rheumatism|October 18, 2017
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiativePil Højgaard, Louise Klokker, Ana-Maria Orbai, et al.
BMC Musculoskeletal Disorders|September 24, 2021
Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patientsBalázs Juhász, Katalin Gulyás, Ágnes Horváth, et al.
Pageof 29